Skip to main content
Top
Published in: Endocrine 1/2022

27-04-2022 | Ultrasound | Original Article

High intensity focused ultrasound in the therapy of benign thyroid nodules—first German bicentric study with long-term follow-up

Authors: Christian Vorländer, Anne Fischer, Hüdayi Korkusuz

Published in: Endocrine | Issue 1/2022

Login to get access

Abstract

Purpose

The study evaluated high-intensity-focused ultrasound (HIFU) for benign thyroid nodules in terms of efficiency, complication rate, influence of preablative nodule size, parameters influencing the therapeutic success and hormonal-thyroid-function.

Methods

Seventy-two patients with 75 nodules were treated with HIFU at 2 centers from 2014–2019. Median nodule volume was 4.4 ml (range 0.33–53). The therapeutic ultrasound probe (EchoPulse THC900888-H) generated 80–90 °C in the target tissue with 87.6–320.3 J per sonication. Nodal volume was measured at baseline and over 12 months after therapy in a retrospective bicentric-study with long-term follow-up. Hormonal-thyroid function (TSH, T3, T4) was measured before and after ablation. Complications were assessed.

Results

Significant volume reduction (p < 0.05 Wilcoxon-signed-rank test) of thyroid nodules was 38.98% at 3 months, 37.32% at 6 months, 61.54% at 9 months and 60.66% at 12 months. Volume reduction of nodules <3 ml did not differ significantly from nodules >3 ml (p > 0.05 Mann–Whitney test). At 3 months solid nodules had a significant volume reduction of 52.08%, complex nodules of 32.57%, nodules treated under regional anesthesia of 33.07% and under general anesthesia of 49.47%. Hormonal-thyroid function was not influenced significantly by HIFU therapy (p > 0.05 Wilcoxon-signed-rank test). Complication rate was 3.8%. No long-term complications occurred.

Conclusion

Significant volume reduction of thyroid nodules up to 12 months after HIFU was shown. All complications were reversible. Therapy was more efficient in solid than complex nodules and in nodules treated under general anesthesia than with regional anesthesia. Hormonal-thyroid-function was not affected.

Trial registraftion number

2020-1728-evBO. Date of registration: 16.06.2020. Agency: Ethik-Kommission bei der Landesäztekammer Hessen
Literature
1.
go back to reference C. Happel, W.T. Kranert, B. Bockisch et al. 131I and 99m Tc-Uptake in focal thyroid autonomies Development in Germany since the 1980s. Nuklearmedizin 55, 236–241 (2016)CrossRef C. Happel, W.T. Kranert, B. Bockisch et al. 131I and 99m Tc-Uptake in focal thyroid autonomies Development in Germany since the 1980s. Nuklearmedizin 55, 236–241 (2016)CrossRef
2.
go back to reference E. Papini, H. Monpeyssen, A. Frasoldati et al. 2020 European Thyroid Association Clinical Practice Guideline for the use of image-guided ablation in benign thyroid nodules. Eur. Thyroid J. 9, 172–185 (2020)CrossRef E. Papini, H. Monpeyssen, A. Frasoldati et al. 2020 European Thyroid Association Clinical Practice Guideline for the use of image-guided ablation in benign thyroid nodules. Eur. Thyroid J. 9, 172–185 (2020)CrossRef
3.
go back to reference M. Sennert, C. Happel, H. Korkusuz et al. Further investigation on high-intensity focused ultrasound (HIFU) treatment for thyroid nodules. Academic Radiol. 2, 88–94 (2018)CrossRef M. Sennert, C. Happel, H. Korkusuz et al. Further investigation on high-intensity focused ultrasound (HIFU) treatment for thyroid nodules. Academic Radiol. 2, 88–94 (2018)CrossRef
4.
go back to reference C. Durante, G. Grani, L. Lamartina, The diagnosis and management of thyroid nodules. JAMA. 319, 914 (2018)CrossRef C. Durante, G. Grani, L. Lamartina, The diagnosis and management of thyroid nodules. JAMA. 319, 914 (2018)CrossRef
5.
go back to reference L. Giovanella, A.M. Avram, I. Iakovou et al. EANM practice guideline/SNMMI procedure standard for RAIU and thyroid scintigraphy. Eur. J. Nucl. Med. Mol. Imaging 46, 2514–2525 (2019)CrossRef L. Giovanella, A.M. Avram, I. Iakovou et al. EANM practice guideline/SNMMI procedure standard for RAIU and thyroid scintigraphy. Eur. J. Nucl. Med. Mol. Imaging 46, 2514–2525 (2019)CrossRef
6.
go back to reference J.H. Yoon, J.Y. Kwak, H.J. Moon et al. The diagnostic accuracy of ultrasound- guided fine-needle aspiration biopsy and the sonographic differences between benign and malignant thyroid nodules 3cm or larger. Thyroid. 21, 993–1000 (2011)CrossRef J.H. Yoon, J.Y. Kwak, H.J. Moon et al. The diagnostic accuracy of ultrasound- guided fine-needle aspiration biopsy and the sonographic differences between benign and malignant thyroid nodules 3cm or larger. Thyroid. 21, 993–1000 (2011)CrossRef
7.
go back to reference M.A. Al Dawish, A. Alwin Robert, M.A. Thabet et al. Thyroid nodule management: thyroid-stimulating hormone, ultrasound, and cytological classification system for predicting malignancy. Cancer Inform. 17, 1176935118765132 (2018)CrossRef M.A. Al Dawish, A. Alwin Robert, M.A. Thabet et al. Thyroid nodule management: thyroid-stimulating hormone, ultrasound, and cytological classification system for predicting malignancy. Cancer Inform. 17, 1176935118765132 (2018)CrossRef
8.
go back to reference L. Delbridge, Solitary thyroid nodule: current management. ANZ J. Surg. 76, 381–386 (2006)CrossRef L. Delbridge, Solitary thyroid nodule: current management. ANZ J. Surg. 76, 381–386 (2006)CrossRef
9.
go back to reference B.R. Haugen, E.K. Alexander, K.C. Bible et al. 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 26, 1–133 (2016)CrossRef B.R. Haugen, E.K. Alexander, K.C. Bible et al. 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 26, 1–133 (2016)CrossRef
10.
go back to reference E.J. Ha, H.K. Lim, J.H. Yoon et al. Primary imaging test and appropriate biopsy methods for thyroid nodules: guidelines by Korean Society of Radiology and National Evidence-Based Healthcare Collaborating Agency. Korean J. Radiol. 19, 623–631 (2018)CrossRef E.J. Ha, H.K. Lim, J.H. Yoon et al. Primary imaging test and appropriate biopsy methods for thyroid nodules: guidelines by Korean Society of Radiology and National Evidence-Based Healthcare Collaborating Agency. Korean J. Radiol. 19, 623–631 (2018)CrossRef
11.
go back to reference B.H.H. Lang, A.L.H. Wu, High intensity focused ultrasound (HIFU) ablation of benign thyroid nodules - a systematic review. J. Ther Ultrasound 5, 11 (2017)CrossRef B.H.H. Lang, A.L.H. Wu, High intensity focused ultrasound (HIFU) ablation of benign thyroid nodules - a systematic review. J. Ther Ultrasound 5, 11 (2017)CrossRef
12.
go back to reference C. Durante, G. Costante, G. Lucisano et al. The natural history of benign thyroid nodules. JAMA. 313, 926 (2015)CrossRef C. Durante, G. Costante, G. Lucisano et al. The natural history of benign thyroid nodules. JAMA. 313, 926 (2015)CrossRef
13.
go back to reference H. Korkusuz, D. Gröner, N. Racynski et al. Thermal ablation of thyroid nodules: are radiofrequency ablation, microwave ablation and high intensity focused ultrasound equally safe and effective methods? Eur. Radiol. 28, 929–935 (2018)CrossRef H. Korkusuz, D. Gröner, N. Racynski et al. Thermal ablation of thyroid nodules: are radiofrequency ablation, microwave ablation and high intensity focused ultrasound equally safe and effective methods? Eur. Radiol. 28, 929–935 (2018)CrossRef
15.
go back to reference M. Dietlein, F. Grünwald, M. Schmidt et al. Radioiodtherapie bei benignen Schilddrüsenerkrankungen (Version 5). Nuklearmedizin 55, 213–220 (2016)CrossRef M. Dietlein, F. Grünwald, M. Schmidt et al. Radioiodtherapie bei benignen Schilddrüsenerkrankungen (Version 5). Nuklearmedizin 55, 213–220 (2016)CrossRef
16.
go back to reference C.J. Balentine, R.S. Sippel, Outpatient thyroidectomy. Surg. Oncol. Clin. N. Am. 25, 61–75 (2016)CrossRef C.J. Balentine, R.S. Sippel, Outpatient thyroidectomy. Surg. Oncol. Clin. N. Am. 25, 61–75 (2016)CrossRef
17.
go back to reference S.R. Chung, J.H. Baek, C.H. Suh et al. Efficacy and safety of high-intensity focused ultrasound (HIFU) for treating benign thyroid nodules: a systematic review and meta-analysis. SAGE J. 61, 1636–1643 (2016) S.R. Chung, J.H. Baek, C.H. Suh et al. Efficacy and safety of high-intensity focused ultrasound (HIFU) for treating benign thyroid nodules: a systematic review and meta-analysis. SAGE J. 61, 1636–1643 (2016)
18.
go back to reference H. Korkusuz, Thermoablation von Schilddrüsenknoten. Nuklearmediziner 39, 227–231 (2016)CrossRef H. Korkusuz, Thermoablation von Schilddrüsenknoten. Nuklearmediziner 39, 227–231 (2016)CrossRef
19.
go back to reference Z. Izadifar, Z. Izadifar, D. Chapman et al. An introduction to high intensity focused ultrasound: systematic review on principles, devices, and clinical applications. JCM 9, 460 (2020)CrossRef Z. Izadifar, Z. Izadifar, D. Chapman et al. An introduction to high intensity focused ultrasound: systematic review on principles, devices, and clinical applications. JCM 9, 460 (2020)CrossRef
20.
go back to reference G. Haar, C. Coussios, High intensity focused ultrasound: physical principles and devices. Int. J. Hyperth. 23, 89–104 (2007)CrossRef G. Haar, C. Coussios, High intensity focused ultrasound: physical principles and devices. Int. J. Hyperth. 23, 89–104 (2007)CrossRef
21.
go back to reference C.R. Hill, G.R. Haar, Review article: high intensity focused ultrasound–potential for cancer treatment. Br. J. Radiol. 68, 1296–1303 (1995)CrossRef C.R. Hill, G.R. Haar, Review article: high intensity focused ultrasound–potential for cancer treatment. Br. J. Radiol. 68, 1296–1303 (1995)CrossRef
22.
go back to reference R. Yang, N.T. Sanghvi, F.J. Rescorla et al. Liver cancer ablation with extracorporeal high-intensity focused ultrasound. Eur. Urol. 23, 17–22 (1993)CrossRef R. Yang, N.T. Sanghvi, F.J. Rescorla et al. Liver cancer ablation with extracorporeal high-intensity focused ultrasound. Eur. Urol. 23, 17–22 (1993)CrossRef
23.
go back to reference H. Korkusuz, M. Sennert, N. Fehre et al. Localized thyroid tissue ablation by high intensity focused ultrasound: volume reduction, effects on thyroid function and immune response. Fortschr. Röntgenstr. 187, 1011–1015 (2015)CrossRef H. Korkusuz, M. Sennert, N. Fehre et al. Localized thyroid tissue ablation by high intensity focused ultrasound: volume reduction, effects on thyroid function and immune response. Fortschr. Röntgenstr. 187, 1011–1015 (2015)CrossRef
24.
go back to reference E. Spartalis, S.P. Karagiannis, N. Plakopitis et al. Single-session high-intensity focused ultrasound (HIFU) ablation for benign thyroid nodules: a systematic review. Expert Rev. Med. Devices 17, 1–13 (2020)CrossRef E. Spartalis, S.P. Karagiannis, N. Plakopitis et al. Single-session high-intensity focused ultrasound (HIFU) ablation for benign thyroid nodules: a systematic review. Expert Rev. Med. Devices 17, 1–13 (2020)CrossRef
25.
go back to reference B.H.H. Lang, Y.C. Woo, K.W.H. Chiu, Single-session high-intensity focused ultrasound treatment in large-sized benign thyroid nodules. Thyroid 27, 714–721 (2017)CrossRef B.H.H. Lang, Y.C. Woo, K.W.H. Chiu, Single-session high-intensity focused ultrasound treatment in large-sized benign thyroid nodules. Thyroid 27, 714–721 (2017)CrossRef
26.
go back to reference P. Trimboli, F. Pelloni, F. Bini et al. High-intensity focused ultrasound (HIFU) for benign thyroid nodules: 2-year follow-up results. Endocrine 65, 312–317 (2019)CrossRef P. Trimboli, F. Pelloni, F. Bini et al. High-intensity focused ultrasound (HIFU) for benign thyroid nodules: 2-year follow-up results. Endocrine 65, 312–317 (2019)CrossRef
27.
go back to reference K. Enomoto, S. Uchino, S. Watanabe et al. Recurrent laryngeal nerve palsy during surgery for benign thyroid diseases: Risk factors and outcome analysis. Surgery 155(3), 522–8 (2014)CrossRef K. Enomoto, S. Uchino, S. Watanabe et al. Recurrent laryngeal nerve palsy during surgery for benign thyroid diseases: Risk factors and outcome analysis. Surgery 155(3), 522–8 (2014)CrossRef
28.
go back to reference D. Lenay-Pinon, A. Biet-Hornstein, V. Strunski, C. Page, The circumstances in which recurrent laryngeal nerve palsy occurs after surgery for benign thyroid disease: a retrospective study of 1026 patients. J. Laryngol. Otol. 135(7), 640–643 (2021)CrossRef D. Lenay-Pinon, A. Biet-Hornstein, V. Strunski, C. Page, The circumstances in which recurrent laryngeal nerve palsy occurs after surgery for benign thyroid disease: a retrospective study of 1026 patients. J. Laryngol. Otol. 135(7), 640–643 (2021)CrossRef
29.
go back to reference J.P. Jeannon, A.A. Orabi, G.A. Bruch et al. Diagnosis of recurrent laryngeal nerve palsy after thyroidectomy: a systematic review. Int. J. Clin. Pract. 63(4), 624–9 (2009)CrossRef J.P. Jeannon, A.A. Orabi, G.A. Bruch et al. Diagnosis of recurrent laryngeal nerve palsy after thyroidectomy: a systematic review. Int. J. Clin. Pract. 63(4), 624–9 (2009)CrossRef
30.
go back to reference E. Lin, S. Lin, J. Fu et al. Neural monitoring during ultrasound-guided radiofrequency ablation of thyroid nodules. Int. J. Hyperthermia 37(1), 1229–1237 (2020)CrossRef E. Lin, S. Lin, J. Fu et al. Neural monitoring during ultrasound-guided radiofrequency ablation of thyroid nodules. Int. J. Hyperthermia 37(1), 1229–1237 (2020)CrossRef
31.
go back to reference C. Kim, J.H. Lee, Y.J. Choi et al. Complications encountered in ultrasonography-guided radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers. Eur. Radiol. 27, 3128–3137 (2017)CrossRef C. Kim, J.H. Lee, Y.J. Choi et al. Complications encountered in ultrasonography-guided radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers. Eur. Radiol. 27, 3128–3137 (2017)CrossRef
32.
go back to reference B. Feng, P. Liang, Z. Cheng et al. Ultrasound-guided percutaneous microwave ablation of benign thyroid nodules: experimental and clinical studies. Eur. J. Endocrinol. 166(6), 1031–1037 (2012)CrossRef B. Feng, P. Liang, Z. Cheng et al. Ultrasound-guided percutaneous microwave ablation of benign thyroid nodules: experimental and clinical studies. Eur. J. Endocrinol. 166(6), 1031–1037 (2012)CrossRef
33.
go back to reference C. Friedrich, C. Ulmer, F. Rieber et al. Safety analysis of vagal nerve stimulation for continuous nerve monitoring during thyroid surgery. Laryngoscope 122(9), 1979–87 (2012)CrossRef C. Friedrich, C. Ulmer, F. Rieber et al. Safety analysis of vagal nerve stimulation for continuous nerve monitoring during thyroid surgery. Laryngoscope 122(9), 1979–87 (2012)CrossRef
34.
go back to reference E. Phelan, R. Schneider, K. Lorenz et al. Continuous vagal IONM prevents recurrent laryngeal nerve paralysis by revealing initial EMG changes of impending neuropraxic injury: a prospective, multicenter study. Laryngoscope 124(6), 1498–505 (2014)CrossRef E. Phelan, R. Schneider, K. Lorenz et al. Continuous vagal IONM prevents recurrent laryngeal nerve paralysis by revealing initial EMG changes of impending neuropraxic injury: a prospective, multicenter study. Laryngoscope 124(6), 1498–505 (2014)CrossRef
35.
go back to reference H. Korkusuz, M. Sennert, N. Fehre et al. Local thyroid tissue ablation by high- intensity focused ultrasound: Effects on thyroid function and first human feasibility study with hot and cold thyroid nodules. Int. J. Hyperthermia 30, 480–485 (2014)CrossRef H. Korkusuz, M. Sennert, N. Fehre et al. Local thyroid tissue ablation by high- intensity focused ultrasound: Effects on thyroid function and first human feasibility study with hot and cold thyroid nodules. Int. J. Hyperthermia 30, 480–485 (2014)CrossRef
36.
go back to reference M. Dietlein, J. Dressler, F. Grünwald, Leitlinie zur Radioiodtherapie (RIT) bei benignen Schilddrüsenerkrankungen [Guidline for radioiodine therapy (RIT for benign thyroid diseases] (Version 4). Nuklearmedizin 46, 220–23 (2007)CrossRef M. Dietlein, J. Dressler, F. Grünwald, Leitlinie zur Radioiodtherapie (RIT) bei benignen Schilddrüsenerkrankungen [Guidline for radioiodine therapy (RIT for benign thyroid diseases] (Version 4). Nuklearmedizin 46, 220–23 (2007)CrossRef
Metadata
Title
High intensity focused ultrasound in the therapy of benign thyroid nodules—first German bicentric study with long-term follow-up
Authors
Christian Vorländer
Anne Fischer
Hüdayi Korkusuz
Publication date
27-04-2022
Publisher
Springer US
Published in
Endocrine / Issue 1/2022
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-022-03058-z

Other articles of this Issue 1/2022

Endocrine 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine